Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local skin immune responses after repeated controlled hookworm infection
NL-OMON57751Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2025
- Modality
- Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label trial of Necator americanus larvae and albendazole in hookworm infection (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Identification of effector cells in the skin and Association between skin reaction and effector cells. Started Oct 2025; status: recruiting.
02
Drugs
Necator americanus larvaealbendazole
03
Conditions
hookworm infection
Beyond the preview
Go deeper on NL-OMON57751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57751.